Clariant celebrates Care Chemicals expansion at Daya Bay, strengthening its position in China

• Clariant completes its Care Chemicals investment of 80 million CHF, significantly expanding production capabilities at its Daya Bay site in China
• The strategic expansion enhances the pharmaceutical capabilities as well as the specialty chemicals production for multiple industries
• Investment reinforces Clariants position as a key player in providing high-value specialty chemicals that meet the increasing quality and performance expectations of Chinese consumers and industries

SHANGHAI, November 5, 2025 - Marking a significant milestone in its Asian growth strategy, Clariant has unveiled its newly expanded state-of-the-art facilities at Daya Bay, China, following the completion of its strategic CHF 80-million investment, substantially boosts Clariant's manufacturing capabilities in one of its key growth markets.

The strategic expansion significantly enhances Clariant's manufacturing capabilities in two key areas: pharmaceutical excipients and specialty chemicals for personal and home care applications. This dual focus reflects Clariant's commitment to meeting growing demand in the Chinese market while strengthening its position as a leading supplier of high-quality specialty chemicals in Asia.

"This investment represents a pivotal moment for Clariant's operations in China," said Christian Vang, Business President Care Chemicals at Clariant. "With these expanded facilities, we are now better positioned to contribute to the health and wellbeing of Chinese consumers while supporting the growth of local industries with our innovative specialty chemicals."

The pharmaceutical capabilities expansion includes a second spray tower specifically designed to serve customers in south China. This enhancement has positioned Clariant as a key supplier for both Active Pharmaceutical Ingredients (APIs) in laxatives and pharmaceutical excipients throughout China. The Daya Bay facility now serves Clariant's healthcare business, maintaining consistent quality standards across China and worldwide.

With over 30 years of experience as a recognized manufacturer of polyethylene glycols (PEGs), Clariant has significantly expanded its Polyglykol capacity at the Daya Bay site. The healthcare product portfolio includes essential ingredients such as VitiPure™, Polyglykol™, Lanogen™, and Motusflex™, which function as solubilizers, emulsifiers, and solvents in pharmaceutical formulations. Additionally, the Polyglykol brand encompasses APIs used in laxative formulations and ophthalmic medicines.

Complementing the pharmaceutical expansion, Clariant has also expanded their multi-purpose plant (MPP) at Daya Bay with an additional reactor. This facility is dedicated to producing specialty chemicals, including mild surfactants for the beauty industry and soil release polymers for the home care sector under the Texcare™ range. These products cater to the growing consumer demand for gentle yet effective personal care products and high-performance home care solutions.

Clariant's Daya Bay expansion features high-performance surfactants, including water-based coatings formulations that reduce VOC emissions and synthetic lubricant ingredients that extend equipment life. In addition, the company offers efficient crop protection additives for precision agriculture and soil health series enhancers that improve water and nutrient retention. These are only a few examples of the company’s commitment to sustainable chemistry solutions addressing China's evolving industrial needs and which deliver solutions balancing efficiency, safety, and sustainability for China's market.

The expansion has also significantly increased Clariant's production capacity for Ethylene Oxide Derivatives (EODs) and a broader chemical portfolio at Daya Bay.

"The evolution of Daya Bay from Clariant's first ethoxylation plant in Asia to an integrated Multi-Purpose Plant and Ethylene Oxide Derivatives site demonstrates our long-term vision for the region," explains Christian Vang. "By bringing our innovation and expertise closer to customers, we're better positioned to help drive their developments forward while addressing our customers sustainability targets and end-product performance needs."

"This expansion not only increases our production capacity but also enhances our ability to collaborate closely with local customers on tailored solutions," added Vang. "We're now better equipped than ever to support the innovation needs of our Chinese customers across the pharmaceutical, personal care, and home care sectors."

The newly opened facilities at Daya Bay will play a crucial role in Clariant's growth strategy in Asia, particularly in China's rapidly evolving specialty chemicals market.

™ ARE TRADEMARKS OF CLARIANT.